Literature DB >> 34952092

Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker.

Yuling Wang1, Vijaya Ramachandran1, Dawen Sui2, Kejing Xu1, Lauren E Haydu1, Shenying Fang1, Jennifer L McQuade3, Sarah B Fisher1, Anthony Lucci1, Emily Z Keung1, Jennifer Wargo1, Jeffrey E Gershenwald1, Merrick I Ross1, Jeffrey E Lee4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34952092      PMCID： PMC9209587          DOI： 10.1016/j.jid.2021.12.012

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   7.590


× No keyword cloud information.
  15 in total

Review 1.  Interleukin-6 and melanoma.

Authors:  Lise Hoejberg; Lars Bastholt; Henrik Schmidt
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

2.  Pretreatment serum interleukin-6 concentration as a prognostic factor of overall survival in metastatic malignant melanoma patients treated with biochemotherapy: a retrospective study.

Authors:  Claude Soubrane; Olivier Rixe; Jean-Baptiste Meric; David Khayat; Roger Mouawad
Journal:  Melanoma Res       Date:  2005-06       Impact factor: 3.599

3.  C-reactive protein as a marker of melanoma progression.

Authors:  Shenying Fang; Yuling Wang; Dawen Sui; Huey Liu; Merrick I Ross; Jeffrey E Gershenwald; Janice N Cormier; Richard E Royal; Anthony Lucci; Christopher W Schacherer; Julie M Gardner; John D Reveille; Roland L Bassett; Li-E Wang; Qingyi Wei; Christopher I Amos; Jeffrey E Lee
Journal:  J Clin Oncol       Date:  2015-03-16       Impact factor: 44.544

4.  Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab.

Authors:  Jon Bjoern; Nikolaj Juul Nitschke; Trine Zeeberg Iversen; Henrik Schmidt; Kirsten Fode; Inge Marie Svane
Journal:  Oncoimmunology       Date:  2015-11-25       Impact factor: 8.110

5.  Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden.

Authors:  R Mouawad; A Benhammouda; O Rixe; E C Antoine; C Borel; M Weil; D Khayat; C Soubrane
Journal:  Clin Cancer Res       Date:  1996-08       Impact factor: 12.531

6.  Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.

Authors:  Shenying Fang; Dawen Sui; Yuling Wang; Huey Liu; Yi-Ju Chiang; Merrick I Ross; Jeffrey E Gershenwald; Janice N Cormier; Richard E Royal; Anthony Lucci; Jennifer Wargo; Mimi I Hu; Julie M Gardner; John D Reveille; Roland L Bassett; Qingyi Wei; Christopher I Amos; Jeffrey E Lee
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

7.  IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.

Authors:  Miao-Fen Chen; Feng-Che Kuan; Tzu-Chen Yen; Ming-Shian Lu; Paul-Yang Lin; Yi-Hsiu Chung; Wen-Cheng Chen; Kuan-Der Lee
Journal:  Oncotarget       Date:  2014-09-30

Review 8.  Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity.

Authors:  Hirotake Tsukamoto; Koji Fujieda; Satoru Senju; Tokunori Ikeda; Hiroyuki Oshiumi; Yasuharu Nishimura
Journal:  Cancer Sci       Date:  2017-11-16       Impact factor: 6.716

9.  Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition.

Authors:  Andressa S Laino; David Woods; Melinda Vassallo; Xiaozhong Qian; Hao Tang; Megan Wind-Rotolo; Jeffrey Weber
Journal:  J Immunother Cancer       Date:  2020-06-23       Impact factor: 13.751

Review 10.  Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes.

Authors:  Samuel I Kim; Christopher R Cassella; Katelyn T Byrne
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561
View more
  2 in total

Review 1.  Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation.

Authors:  Peter Gál; Jan Brábek; Michal Holub; Milan Jakubek; Aleksi Šedo; Lukáš Lacina; Karolína Strnadová; Petr Dubový; Helena Hornychová; Aleš Ryška; Karel Smetana
Journal:  Histochem Cell Biol       Date:  2022-07-22       Impact factor: 2.531

2.  Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Authors:  Xin-Cheng Mao; Chun-Cheng Yang; Ya-Fei Yang; Lun-Jie Yan; Zi-Niu Ding; Hui Liu; Yu-Chuan Yan; Zhao-Ru Dong; Dong-Xu Wang; Tao Li
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.